Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
NCT ID: NCT05038852
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
8 participants
INTERVENTIONAL
2019-04-12
2027-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment
NCT03519451
Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study
NCT05763771
BREATHE Free: a Pilot Feasibility Trial
NCT06862050
Smoking, Stress, and Mobile Technology
NCT04838236
Efficacy of Smartphone App for Smoking Cessation in China
NCT04421170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Exploratory analyses including covariates such as nicotine dependence, mood, and depressive symptoms may be examined as appropriate, as these measures have been shown to predict abstinence outcomes in a variety of studies.1-4 Changes in mood and/or depressive symptoms may also be characterized
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 smartphone applications
app is designed to help you learn relaxation skills
smartphone applications
app is designed to help you learn relaxation skills.
smartphone applications
app is designed to help you increase your positive feelings, behaviors, and thoughts.
Group 2 smartphone applications
app is designed to help you increase your positive feelings, behaviors, and thoughts.
smartphone applications
app is designed to help you learn relaxation skills.
smartphone applications
app is designed to help you increase your positive feelings, behaviors, and thoughts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smartphone applications
app is designed to help you learn relaxation skills.
smartphone applications
app is designed to help you increase your positive feelings, behaviors, and thoughts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current smoker (i.e., at least 1 cigarette or e-cig per day)
* smoking for at least one year,
* willing to set a quit date in the next 30 days,
* not engaged in smoking cessation treatment other than the MDACC Tobacco Treatment Program
* English speaking and ability to read and comprehend English, and 7) currently own an iOS mobile phone (iPhone) using iOS 9.0 or later and reports regular use (at least weekly) of at least 1 iOS app.
Exclusion Criteria
* meeting criteria for a current Major Depressive Episode measured by the PHQ-9,
* any medical or psychiatric condition, illness, disorder, or concomitant medication that could compromise participant safety or treatment, as determined by the Principal Investigator or Collaborator,
* subject considered by the investigator an unsuitable candidate for receipt of a smoking cessation treatment or unstable to be followed up throughout the entire duration of the study.
* Pregnant women will not be excluded from participating in the study and any decisions about potential pharmacotherapy will be done as standard of care in the Tobacco Treatment Program, including a consultation with the medical team and a joint decision-making process with the patient to determine the best course of treatment given all co-morbid medical conditions.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Minnix
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-09413
Identifier Type: OTHER
Identifier Source: secondary_id
2018-0984
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.